Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,088.94
(
-0.52%
)
US TECH 100
25,732.71
(
-0.85%
)
Dow Jones
49,313.82
(
-0.27%
)
Brent Oil
92.17
(
-0.53%
)
Bitcoin
75,211.83
(
1.83%
)
News Focus
News Focus
Post# of 257428
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

HobGlobulin

Send PM Follow Ignore
Followers 4
Posts 211
Boards Moderated 0
Alias Born 03/09/2007

HobGlobulin

Re: DewDiligence post# 62968

Wednesday, 05/28/2008 10:18:20 AM

Wednesday, May 28, 2008 10:18:20 AM

Post# of 257428
RE:SNUS merges with private firm, OncoGenex Technologies:

OncoGenex is pursuing cancer treatments using antisense licensed from Isis Pharmaceuticals. LLY is also developing antisense cancer treatments based on Isis IP.

First generation antisense had a lugubrious track record with regard to cancer (and virtually everything else.) It seems noteworthy that LLY is still aboard after the Affinitak debacle.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today